China Universal Asset Management »

Avadel Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $243k 19k 13.12
2024-06-30 $159k 11k 14.06

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Avadel Pharmaceuticals

Henderson Group
Jeffrey L. Gendell
BlackRock
BlackRock
Vanguard Group
Braidwell
Citadel Advisors
Wealth Effects
Two Seas Capital
Vestal Point Capital
Woodline Partners
Brandes Investment Partners
Tang Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Avadel Pharmaceuticals